Literature DB >> 16548774

Multifunctional transcription factor YY1: a therapeutic target in human cancer?

Chi-Chung Wang1, Jeremy J W Chen, Pan-Chyr Yang.   

Abstract

The multifunctional transcription factor Yin Yang 1 (YY1) is a complex protein that has been shown to play pivotal roles in development, differentiation, cellular proliferation and apoptosis. It can act as a transcriptional repressor, an activator, or an initiator element binding protein that directs and initiates transcription of numerous cellular and viral genes. Because the expression and function of YY1 are known to be intimately associated with cell-cycle progression, the physiological significance of YY1 activity has recently been applied to models of cancer biology. Several lines of evidence imply that YY1 expression and/or activation is associated with tumourigenesis, in addition to its regulatory roles in normal biological processes. However, controversial results also raised and indicated that further studies are still needed to piece all of the seemingly contradictory data into a complete picture. On the basis of YY1 regulations and functions, novel drugs and specific treatment strategies may be developed with new therapeutic applications for tumour patients in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548774     DOI: 10.1517/14728222.10.2.253

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  19 in total

1.  In-cell fluorescence activation and labeling of proteins mediated by FRET-quenched split inteins.

Authors:  Radhika Borra; Dezheng Dong; Ahmed Y Elnagar; Getachew A Woldemariam; Julio A Camarero
Journal:  J Am Chem Soc       Date:  2012-03-28       Impact factor: 15.419

Review 2.  Polycomb group response elements in Drosophila and vertebrates.

Authors:  Judith A Kassis; J Lesley Brown
Journal:  Adv Genet       Date:  2013       Impact factor: 1.944

3.  Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity.

Authors:  Seok-Geun Lee; Keetae Kim; Timothy P Kegelman; Rupesh Dash; Swadesh K Das; Jung Kyoung Choi; Luni Emdad; Eric L Howlett; Hyun Yong Jeon; Zhao Zhong Su; Byoung Kwon Yoo; Devanand Sarkar; Sung-Hoon Kim; Dong-Chul Kang; Paul B Fisher
Journal:  Cancer Res       Date:  2011-08-18       Impact factor: 12.701

Review 4.  Cyclotides: Overview and Biotechnological Applications.

Authors:  Andrew Gould; Julio A Camarero
Journal:  Chembiochem       Date:  2017-05-24       Impact factor: 3.164

Review 5.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

6.  The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Authors:  Jason G Lieberthal; Marissa Kaminsky; Christopher N Parkhurst; Naoko Tanese
Journal:  Breast Cancer Res       Date:  2009-06-30       Impact factor: 6.466

7.  Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.

Authors:  Desmond G Powe; Gulfareen Akhtar; Hany Onsy Habashy; Tarek Abdel-Fatah; Emad A Rakha; Andrew R Green; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2009-12-21       Impact factor: 6.466

Review 8.  Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.

Authors:  Julio A Camarero
Journal:  Bioorg Med Chem Lett       Date:  2017-10-21       Impact factor: 2.823

9.  Yin yang 1 modulates taxane response in epithelial ovarian cancer.

Authors:  Noriomi Matsumura; Zhiqing Huang; Tsukasa Baba; Paula S Lee; Jason C Barnett; Seiichi Mori; Jeffrey T Chang; Wen-Lin Kuo; Alison H Gusberg; Regina S Whitaker; Joe W Gray; Shingo Fujii; Andrew Berchuck; Susan K Murphy
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

10.  Periostin as a heterofunctional regulator of cardiac development and disease.

Authors:  Simon J Conway; Jeffery D Molkentin
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.